Bolt Biotherapeutics, Inc. (BOLT) Shareholders’ equity 2020–2025
Bolt Biotherapeutics, Inc. (BOLT) shareholders’ equity at each fiscal year-end, per SEC filings.
$26.5MFY2025 · since FY2020: -$104.9M → $26.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $26.5M | -53.7% |
| FY2024 | $57.2M | -49.3% |
| FY2023 | $112.7M | -34.3% |
| FY2022 | $171.5M | -31.4% |
| FY2021 | $250.1M | +338.3% |
| FY2020 | -$104.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice